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In the 1990s, three sets of ﬁndings suggested
that hormonally active agents may cause
adverse health effects in humans and wildlife
and thereby contribute to environmental
degradation (Colborn et al. 1993). First,
researchers discovered wildlife showing
developmental, neurologic, and endocrine
alterations, even after the ban of known
estrogenic pesticides. Meanwhile, epidemio-
logic studies revealed increased incidences of
breast and testicular cancers and alterations
of the male genital tract (Davis et al. 1993;
Sharpe and Skakkebaek 1993). Furthermore,
chemicals introduced into the environment
since 1950 were found to have hormone ago-
nistic and antagonistic activity. It was
hypothesized that health effects observed in
humans and wildlife may be due to these
endocrine-active chemicals, known as
endocrine disruptors (Colborn et al. 1993).
The E-SCREEN assay, developed to meas-
ure estrogenic activity using cell number as
the end point (Soto et al. 1992, 1999), is
used to identify estrogenic chemicals among
environmental pollutants and is among the
most sensitive and reproducible assays for
estrogenic activity (Andersen et al. 1999;
Fang et al. 2000).
Estrogen mimics were the majority of
active agents ﬁrst identiﬁed, although andro-
gen agonists and antagonists were also found
among environmental pollutants (Gray et al.
1999a, 1999b). These discoveries prompted
the development of in vitro androgen agonist
and antagonist assays such as the A-SCREEN
(Soto et al. 1999).
Among more than 70,000 synthetic
chemicals registered for commercial use, few
were tested for hormonal activity. Because
hormonal activity is not easily predictable,
bioassays are necessary [Endocrine Disruptor
Screening and Testing Advisory (EDSTAC)
1998]. In vitro tests were also adapted to
detect estrogenic activity in wastewater and
watercourses. Pairing water extract fractiona-
tion with instrumental analysis allowed for
the identiﬁcation of chemicals contributing to
hormonal activity (Routledge et al. 1998).
Fish exposed to these waters showed signs of
endocrine disruption (Jobling et al. 1998).
Anabolic agents are used in the cattle
industry to increase growth. The androgens
testosterone and trenbolone acetate (TbA),
the estrogens 17β-estradiol (17β-E2) and zer-
anol, and the progestogens progesterone and
melengestrol acetate (MGA) (Lange et al.
2001) are the primary growth promoters used
in the United States. Meat from anabolic
steroid–treated cattle is purported to cause
minimal human exposure because hormone
treatment is stopped days before slaughter
(Daxenberger et al. 2001). However, estro-
genic esters of fatty acids, which are more
potent than the parent compound when
administered per os, have been identified in
meat from anabolic steroid–treated cattle
(Maume et al. 2001).
The ultimate fate of many excreted ana-
bolic agents is unknown; however, measur-
able amounts of hormones are released from
farm animals and reach the environment
(Lange et al. 2002). Moreover, recent studies
show that metabolites of TbA can remain in
manure piles for more than 270 days, sug-
gesting that these compounds are likely pre-
sent downstream from cattle farms if excreta
enter these waterways (Schiffer et al. 2001).
In addition, estrogens and androgens have
been reported in streams receiving runoff
from fields fertilized with chicken litter
(Finlay-Moore et al. 2000). Hence, we expect
that both natural sex steroids in cattle and the
metabolites of anabolic hormones adminis-
tered to them would be present in the water
downstream from cattle ranches.
In the present study, we tested the hypoth-
esis that concentrated animal feeding opera-
tions (CAFOs) release signiﬁcant amounts of
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Studies reveal that surface waters worldwide are contaminated with hormonally active agents, many
released from sewage treatment plants. Another potential source of aquatic hormonal contamina-
tion is livestock feedlot efﬂuent. In this study, we assessed whether feedlot efﬂuent contaminates
watercourses by measuring a) total androgenic [methyltrienolone (R1881) equivalents] and estro-
genic (17β-estradiol equivalents) activity using the A-SCREEN and E-SCREEN bioassays and
b) concentrations of anabolic agents via gas chromatography–mass spectroscopy and enzyme-based
immunoassays. Water samples were collected over 3 years from up to six sites [all conﬂuent with
the Elkhorn River, Nebraska, USA: a feedlot retention pond (site 1), a site downstream from site 1
(site 2), a stream with intermediate livestock impact (site 3), and three sites with no observable
livestock impact (sites 4–6)] and two sources of tap water. In 1999, samples from site 1 contained
9.6 pM R1881 equivalents and 1.7 pM 17β-estradiol equivalents. Site 2 samples had estrogen lev-
els similar to those in site 1 samples but lower androgen levels (3.8 pM R1881 equivalents).
Androgen levels in site 3 samples were similar to those in site 2 samples, whereas estrogen levels
decreased to 0.7 pM 17β-estradiol equivalents. At site 6, androgen levels were approximately half
those found at site 3, and estrogen levels were comparable with those at site 3. Sampling in later
years was limited to fewer sites because of drought and lack of permission to access one site.
Instrumental analysis revealed estrone but no signiﬁcant levels of resorcylic acid lactones or tren-
bolone metabolites. Tap water was devoid of hormonal activity. We conclude that feedlot efﬂuents
contain sufficient levels of hormonally active agents to warrant further investigation of possible
effects on aquatic ecosystem health. Key words: agricultural runoff, anabolic steroid hormones,
aquatic ecosystem health, A-SCREEN, concentrated animal feeding operations (CAFOs), environ-
mental androgens, environmental estrogens, E-SCREEN, personal care products, pharmaceuticals.
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metabolites into the environment. The down-
stream hormonal contamination of such opera-
tions would potentially alter the reproductive
and endocrine systems of exposed organisms.
Materials and Methods
Supplies. We purchased melengestrol from
Biomol Research Laboratories (Plymouth
Meeting, PA, USA); 17β-E2 from Calbiochem
(San Diego, CA, USA); and methyltrienolone
(R1881) from New England Nuclear (Perkin-
Elmer Life Sciences, Boston, MA, USA).
Francois André (LABERCA-National Reference
Laboratory, Nantes, France) provided tren-
bolone-17α (Tb-17α), Tb-17β, and trendione
(TbO). All other hormones were obtained
from Sigma Chemical Company (St. Louis,
MO, USA). Immunoafﬁnity chromatography
columns for Tb and 19-nortestosterone (cata-
log no. TB 2186) were purchased from
Randox Laboratories (San Diego, CA, USA).
Research sites. This study complements
one by Orlando et al. (2004) on the endocrine-
disrupting effects of cattle feedlot efﬂuent on
the fathead minnow, Pimephales promelas.
Water was collected over a 3-year period from
six sites conﬂuent with the Elkhorn River in
Nebraska (Figure 1). In June 1999, water sam-
ples were obtained from a cattle efﬂuent hold-
ing pond directly below a feedlot (retention
pond: site 1), a drainage canal 0.5 km down-
stream that channels water from the feedlot
into the Elkhorn River (contaminated site:
site 2), a stream draining ﬁelds with dispersed
cattle and agricultural activity (intermediate
exposure site: site 3), and three tributaries of
the Elkhorn River with no apparent feedlot
activity in the surrounding area (sites 4–6).
Only one of these (reference site: site 6) yielded
the proper sample size of fathead minnows
required by Orlando et al. (2004) for their
study. This site was located within the Oak
Valley State Wildlife Management Area,
approximately 80 km from the feedlot. In
addition, tap water samples were acquired from
the hose bibs of a recreation center (T1) and a
recreational vehicle station center (T2) at a
riverside park near site 3. Sampling in
September 2000 and July 2001 was limited to
sites 1, 3, and 6. Site 2 was not sampled after
June 1999 because it was on private land and
permission for additional samplings was not
obtained. Site 3 was visited in both sampling
periods, but drought prevented collection of
water during September 2000.
Test sample preparation and extraction.
Water from the retention pond and streams
was collected by immersion of amber glass bot-
tles: September 1999, 4-L bottles precleaned
by U.S. Environmental Protection Agency
(U.S. EPA) standards (Fisher Scientific,
Pittsburgh, PA, USA); September 2000 and
July 2001, precleaned 2.5-L bottles (catalog
no. 2500-0250; Environmental Sampling
Supply, Oakland, CA, USA). Tap water was
collected from the hose bibs into the same
bottles. We took from 8 L (1999) to 10 L
(2000, 2001) from each site and added 0.02%
sodium azide to avoid microbial degradation.
Southwest Research Institute (SwRI; San
Antonio, TX, USA) received the bottles and
kept them at 4°C until extraction. SwRI pre-
pared laboratory water blanks from distilled
water samples.
We assessed the recovery of compounds
likely to be in the ﬁeld samples by spiking 2 L
distilled water samples. Each analyte was
spiked to 0.5 µg/L, except for Tb, which was
spiked to 2.5 µg/L. We tried three extraction
methods: dichloromethane (DCM), 6%
ethyl ether–hexane, and 50% ethyl ether–
hexane. Because DCM gave the best results,
we used this for the ﬁeld water samples.
Each sample was split into four 1-L frac-
tions in 2-L glass separatory funnels. All glass-
ware was rinsed with 0.6% HCl in DCM and
allowed to dry. Each 1-L fraction was
extracted three times with 60-mL portions of
DCM by shaking 2 min and waiting for at
least 10 min before draining the DCM into a
500-mL glass bottle. The DCM extracts of the
four fractions were then combined into the
same glass bottle. The DCM extracts were
concentrated to 2 mL using nitrogen on an N-
EVAP evaporator (Organomation Associates,
Berlin, MA, USA) maintained at 40°C. A
1-mL fraction was removed and solvent
exchanged to 100 µL ethanol. The remaining
1-mL fraction was submitted for gas chro-
matography–mass spectrometry (GC-MS)
analysis as described below.
The spiked samples were solvent exchanged
to acetonitrile and derivatized with N,O-
bis(trimethylsilyl)triﬂuoroacetamide (BSTFA;
Regis Technologies, Morton Grove, IL, USA)
for 4 hr at 70°C. Seven calibration standards,
ranging from 15 to 1,000 ng/µL, were pre-
pared in acetonitrile and derivatized using
BSTFA under the same conditions as samples
before GC-MS analysis. External standard cali-
bration was used to generate the response fac-
tors and to generate a ﬁrst-order ﬁt to check
the linearity of the calibration curve.
Preparation of samples for Tb analysis by
afﬁnity chromatography. This procedure was
used only for July 2001 ﬁeld samples. We used
Randox immunoaffinity columns (Randox
Laboratories) for Tb/19-nortestosterone.
Phosphate buffer was added to each 10-L ﬁeld
sample, and samples were passed through the
columns following the supplier’s protocol. A
total volume of 1 L (900 mL of water sample
and 100 mL phosphate buffer) was passed
through the cartridge. Bound androgens were
eluted with 4 mL 70% MeOH/30% water.
The eluates were pooled, concentrated to 1 mL,
and solvent exchanged to 100% ethanol.
A 200-µL aliquot was used for A-SCREEN and
E-SCREEN assays, and an 800-µL aliquot was
used for HPLC separation and enzyme
immunoassay (EIA).
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Figure 1. Map of eastern Nebraska showing the six
collection sites where water was obtained in June
1999 (sites 1–6). During September 2000 and July
2001, water was collected only at sites 1 and 6 and
at sites 1, 3, and 6, respectively, because of drought
conditions at the other sites. Cell lines and culture conditions.
Maintenance and propagation of estrogen-tar-
get MCF7-BOS cells (Villalobos et al. 1995)
and androgen-target MCF7-AR1 cells (Szelei
et al. 1997) were performed as previously
described (Soto et al. 1999). Charcoal–dex-
tran stripping of fetal bovine serum (CDFBS)
was performed as previously described (Soto
et al. 1991).
E-SCREEN bioassay. Human breast cancer
MCF7 cells are plated into 24-well plates
(Linbro, ICN Biomedical, Costa Mesa, CA,
USA) at an initial density of 20,000–30,000
cells/well in 1 mL Dulbecco’s modiﬁcation of
Eagle’s medium (DMEM; ICN Biomedical)
supplemented with 5% fetal bovine serum
(HyClone, Logan, UT, USA). The cells were
dispersed evenly in each well and allowed to
attach for 24 hr. The seeding medium was
then replaced with sample extracts diluted with
5% CDFBS in phenol red–free DMEM
(Irvine Scientiﬁc, Santa Ana, CA, USA).
Each experiment includes a 17β-E2 stan-
dard dose–response curve with 15 dilutions of
17β-E2 (0.05 pM–10.0 nM) in quadruplicate
wells, run simultaneously with the samples.
Results from the water sample extracts are
interpolated into this dose–response curve.
Water extracts (100 µL in ethanol) were
prepared by adding 5% CDFBS to a final
volume of 10 mL and tested at ﬁve different
concentrations to ensure a cell number near
the half-maximal level (M50) of the 17β-E2
dose–response curve. Water blanks and T1
and T2 samples were tested at 100-, 50-, 25-,
6.25-, and 1.25-fold greater than the initial
water concentration. Field samples 1–6 were
ﬁrst tested at the same concentrations as the
water blanks. Once the range of estrogenic
activity had been established, a detailed con-
centration curve was run within that range to
accurately measure estrogenic activity. On
each 24-well plate we tested five concentra-
tions from one extract in duplicate, plus neg-
ative (5% CDFBS) and positive controls
(5% CDFBS plus 100 pM 17β-E2). Assays
for each water extract were repeated three to
ﬁve times.
To evaluate potential cytotoxicity, each
extract dilution was also tested in the presence
of 100 pM 17β-E2 to induce maximal prolif-
eration. If maximal proliferation was achieved,
it was interpreted as a lack of toxicity. If the
cell number was less than the positive control,
it was used to qualify the results of that partic-
ular extract concentration as cytotoxic. In
addition, cytotoxicity was identiﬁed through
microscopic observation before ﬁxation.
A-SCREEN bioassay. This assay uses
MCF7-AR1 cells, which are stable transfectants
of MCF7 cells expressing the wild-type human
androgen receptor (Szelei et al. 1997). These
cells proliferate maximally in 5% CDFBS and
100 pM 17β-E2, and respond to androgens by
decreasing their proliferation rate. The assay
compares the cell number of similar inocula of
MCF7-AR1 cells grown in 5% CDFBS,
5% CDFBS plus 100 pM 17β-E2, and
5% CDFBS/100 pM 17β-E2 plus a range of
concentrations of the synthetic, nonmetaboliz-
able androgen R1881 (positive control) and a
range of concentrations of a suspected andro-
gen mimic (Soto et al. 1999). Each sample was
assayed three to ﬁve times.
Field samples were analyzed by testing
several dilutions of the ethanolic extract as
described above for the E-SCREEN assay.
The test samples, their corresponding field
blanks, and an R1881 dose–response curve
were processed simultaneously.
Processing for cell counting. We used ﬁxa-
tion and staining techniques previously
described by Villalobos et al. (1995). The
bound sulforhodamine B (SRB) dye was solubi-
lized using 500 µL 10 mM Tris base (pH 10.5)
per well; triplicate 100-µL aliquots were trans-
ferred to 96-well plates (Becton Dickinson,
Franklin Lanes, NJ, USA) and scanned in a
computerized microplate reader (Series 750;
Cambridge Technology, Inc., Watertown, MA,
USA) at 515 nm wavelength. The relationship
between optical density and cell number was
established by comparing different cell inocula
and counting half of the wells with a Coulter
counter (Coulter Electronics, Hialeah, FL,
USA) and half via the SRB method.
Data analysis. 17β-E2 and R1881
dose–response curves were used as standards
to quantify estrogenic and androgenic activity
of samples in 17β-E2 equivalents (E2Eq) or
R1881 equivalents (AEq). We expressed the
cell number corresponding to each 17β-E2 (or
R1881) concentration relative to the maximal
cell number from the experiment with the
following equation:
We then logit-transformed the B/B0 ratio and
ran a simple linear regression of logit B/B0 on
the natural log of the 17β-E2 (or R1881) con-
centration and graphed the linearized curve.
We excluded points with B/B0 < 0.15 or
> 0.85, because these points fall near the
asymptotes (< 0.15, below detection limits;
> 0.85, in the plateau) where the relationship
between dose and effect is meaningless
(Feldman and Rodbard 1971). The slope and
y-intercept of the linear logit-transformed
dose–response curve were then used to calcu-
late the E2Eq or AEq corresponding to B/B0
for any tested samples.
Conversion of analytical data into hor-
mone equivalent units. M50 is the concentra-
tion producing an estrogenic (or androgenic)
effect that is 50% of the maximal response.
This parameter is measured to assess the
potency of agonists, relative to the standard.
The relative proliferative potencies (RPPs)
were calculated as (M50 17β-E2 or R1881) ÷
(M50 test chemical). Based on the mean M50,
the “predicted” estrogen/androgen total load
was calculated and compared with the actual
values obtained by measuring bioactivity with
the E-SCREEN and A-SCREEN assays.
All target analytes [estrone (E1), 17β-E2,
Tb-17α, Tb-17β, the six resorcylic acid lac-
tones (α-zearalenol, β-zearalenol, α-zearalanol,
β-zearalanol, zearalenone, zearalanone), and
MGA] were assayed using both the E-SCREEN
and the A-SCREEN assays.
Immunometric detection of estrogens and
androgens. Water extracts (100-µL aliquots)
were diluted with purified water (Millipore-
Milli-Q-PLUS Puriﬁcation Pak CPMQ004R1;
Millipore Corp., Billerca, MA, USA) to a ﬁnal
ethanol concentration of 20% and passed
through 100-mg octadecyl silica gel cartridges
(Bakerbond solid-phase extraction C18; J.T.
Baker Inc., Phillipsburg, NJ, USA). Cartridges
were washed with 2 × 1 mL methanol and
equilibrated with 2 × 1 mL 20 mM Tris-HCl
(pH 8.5)/methanol 80/20 (vol/vol). After sam-
ple application, the cartridge was washed twice
each with 1 mL 20 mM Tris-HCl (pH
8.5)/methanol 80/20 (vol/vol) and 40% aque-
ous methanol. Hormones were eluted with
1 mL 80% aqueous methanol.
The solvent was evaporated at 60°C
under reduced pressure (3 hPa; Unijet II, Uni
Equip, Munich, Germany). For HPLC analy-
sis, the residue was redissolved in 300 µL
20 mM Tris-acetate (pH 7.2)/acetonitrile
80/20 (vol/vol) for E2 or 300 µL purified
water/methanol 80/20 (vol/vol) for Tb.
According to previously established proce-
dures (Lange et al. 2001; Schiffer et al. 2001),
the extracts were processed via HPLC and
prepared for analysis by specific immuno-
metric methods (EIA). The estrogen and Tb
fractions were analyzed by EIA as previously
described (Meyer and Hoffmann 1987;
Meyer et al. 1997).
GC-MS detection of anabolic agents. For
low-resolution measurements of anabolic
agents, we used an Agilent 5973 single-
quadrupole mass spectrometer (Palo Alto, CA,
USA), coupled with an Agilent 6890 gas chro-
matograph used with an Agilent DB-5.625
(30 mm × 0.25 mm inner diameter ×
0.25 µm) analytical column (inlet tempera-
ture, 275°C; injection volume, 2 µL; J&W
Scientiﬁc, Folsom, CA, USA). The injection
mode was pulsed splitless with a 1-min purge
time and a 50 mL/min purge ﬂow. The carrier
gas was helium. The oven temperature was
programmed for 60°C (1 min) and 8°C/min
to 310°C (5 min), and the transfer line tem-
perature was 280°C. Temperatures were set at
150°C and 230°C for the quadrupoles and
source, respectively. We used electron impact
B
B
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data were acquired under selected ion moni-
toring (SIM) mode in which three to four
ions per compound were scanned to enhance
sensitivity.
For high-resolution measurements, the
ethanolic extracts were further purified 
for GC–high resolution MS (GC-HRMS)
through three solid-phase extraction columns
(C18, diol, and silica) (Maume et al. 2001).
The derivatization reagents included
n-methyl-n-trimethylsilyl-triﬂuoroacetamide,
and trimethyliodosilane (Fluka, Buchs,
Switzerland). The measurements were
obtained as described by Maume et al. (2001)
using EI ionization and SIM acquisition with
perfluorokerosene providing the “lock” mass
and 1,3,5(10)-estratriene-16,16,17-d3-17β-
diol providing the internal standard.
Results
Choice of extraction method. Neither 6% nor
50% ethyl ether–hexane gave acceptable
recoveries. Extraction with DCM gave accept-
able recoveries for all the analytes of interest:
102% for estrone (E1), 87% for 17β-E2, 99%
for testosterone, 103% for Tb-17α, 100% for
Tb-17β, and between 95% and 101% for six
resorcylic acid lactones. 
Hormonal activity of anabolic compounds.
The M50 values for the resorcylic acid lac-
tones were as follows: α-zearalenol, 50 pM;
β-zearalenol, 4.3 nM; α-zearalanol, 0.13 nM;
β-zearalanol, 0.6 nM; zearalenone, 0.94 nM;
and zearalanone, 0.43 nM, compared with
7.5 pM for 17β-E2. Androgens (up to 1 µM)
had no estrogenic activity.
The M50 of the isomers Tb-17α and
Tb-17β were 2.35 and 0.15 nM, respectively;
the latter had similar potency to dihydro-
testosterone (M50, 75 pM) and R1881 (M50,
68.4 pM). MGA had neither estrogenic nor
androgenic activity.
Dose–response curves for 17β-E2 and
R1881. The M50 values were 7.5 ± 2.1 pM for
17β-E2 (n = 9) and 68.4 ± 23.1 pM for
R1881 (n = 7). The R2 values for 17β-E2
(n = 9) and R1881 (n = 7) were 0.97 ± 0.04
and 0.97 ± 0.03, respectively. Figure 2 depicts
the 17β-E2 and R1881 dose–response curves.
Estrogen and androgen activity in the
field samples. For June 1999 field samples,
both estrogen and androgen activities were
highest in site 1 samples. There was a marked
decline of androgen activity in site 2 samples,
comparable with that in samples from sites
3–5. Site 6 samples exhibited a lower activity,
about 45–50% that of samples from sites 2–5
and about 25% that of site 1 samples; andro-
gen activity of samples was as follows (in
picomoles AEq): site 1, 9.62 ± 1.5%; site 2,
3.83 ± 14%; site 3, 4.58 ± 1%; site 4, 3.89 ±
14%; site 5, 4.58 ± 7.2%; and site 6, 2.45 ±
16%. In contrast, estrogenic activity was sim-
ilar at sites 1 and 2 and roughly 50% lower at
site 6 (Figure 3); estrogenic activity of sam-
ples was as follows (in picomoles E2Eq):
site 1, 1.73 ± 6.2%; site 2, 2.23 ± 17%;
site 3, 0.65 ± 1.5%; site 4, 0.78 ± 16%;
site 5, 0.76 ± 19%; and site 6, 1.15 ± 19%.
No estrogenic or androgenic activity was
found in drinking water (T1 and T2) or in
the water blanks. Detection of estrogens and
androgens by EIA and GC-MS was problem-
atic because of the low signal-to-noise ratio.
We tested for Tb-17β and its metabolites
Tb-17α and TbO, as well as zeranol,
17β-E2, 17α-E2, and E1. The only analyte
measurable in these conditions of extremely
high noise was E1 (Table 1). There was a
6-fold difference between E1 activities at
sites 1 (1,650 pg/L) and 6 (270 pg/L); E1
activity at site 2 was 354 pg/L. E1 was below
detection limits in T1 and T2 samples. The
detection limit for these two samples was
1–3 pg/L, two orders of magnitude below the
levels found in field samples. These values
were confirmed by GC-HRMS. E2-17α was
detected only at site 5 (19 pg/L).
We measured the RPP of E1 (relative to
17β-E2) to assess the proportion of estrogenic
activity detected in the E-SCREEN assay that
is due to E1 (RPP, 0.0436). The estrogenic
activity of E1 accounted for a variable portion
(between 3% and 46%) of estrogenic activity
found by the E-SCREEN assay (Table 1).
To identify the analytes responsible for
the hormonal activity, we collected samples
again in September 2000. We detected both
androgenic and estrogenic activity (Table 2).
Detection of Tb and zeranol was thwarted
because of high noise. E1 was positive
(8,300 pg/L) and represented 36.34% of the
total estrogenic activity detected by the
E-SCREEN (Table 3). 17α-E2, 17β-E2, and
E1 were also analyzed by GC-HRMS, yield-
ing comparable results (Table 3). These
results suggest that other estrogens in addi-
tion to our target analytes could have been
present.
To decrease noise and enable the detec-
tion of Tb and its metabolites in July 2001
field samples, we chromatographed water
samples taken from sites 1, 3, and 6 through
Tb/19-nortestosterone immunoaffinity
columns. The A-SCREEN revealed 1.37, 0.5,
and 0.19 pM AEq at sites 1, 3, and 6, respec-
tively, and no activity in the water blanks.
However, the puriﬁcation yield was not meas-
ured because a tracer would interfere with the
bioactivity assays. As expected, the E-SCREEN
assay detected no estrogenic activity in these
supposedly androgen-only preparations
(Table 2). Tb-17β, Tb-17α, and TbO were
detected, albeit at concentrations about
100-fold lower than that needed for androgen
detection by the A-SCREEN (Table 4). The
extremely low level at site 1 (theoretically the
most polluted), and the low but detectable lev-
els of Tb-17α and TbO in the water blanks
suggest that these data may be artifactual.
Water blanks processed later revealed unde-
tectable levels of the three Tb-related analytes.
Discussion
The recent increase in the number of CAFOs
raises concerns that their wastewater may cont-
aminate downstream watercourses and thereby
contribute to environmental degradation.
According to the new U.S. EPA ruling (U.S.
EPA 2003), more CAFOs will be required to
seek discharge permits under the Clean Water
Act (1970) and to develop and implement
nutrient management plans.
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Figure 2. Standard dose–response curves for (A) the E-SCREEN bioassay (MCF7-BOS cells grown in
5% CDFBS supplemented with 17β-E2) and (B) the A-SCREEN bioassay (MCF7-AR1 cells grown in CD-DME
supplemented with R1881). Error bars indicate SD.
Figure 3. Hormonal activity of water draining from the
feedlot. Samples were collected in September 1999.
B, water blank. Activity is expressed as E2Eq or AEq
in the original water sample. Error bars indicate SD.
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E2EqOur original purpose was to compare hor-
monal activities and proﬁles in the runoff from
CAFOs that supplement their cattle with hor-
mones with those in runoff from CAFOs that
do not. We were unable to identify any sites
where animals were raised without hormone
supplements in a feedlot setting. In hindsight,
this is not surprising because hormone supple-
ments are given to approximately 90% of U.S.
beef cattle (Balter 1999). Cattle raised without
hormone supplements are usually raised at low
density on open rangeland; hence, their excreta
should present a substantially lower environ-
mental burden.
The hormones are usually given in the form
of implants; the implants currently marketed
contain pharmaceuticals with androgenic
(testosterone, TbA), estrogenic (17β-E2, zera-
nol), or progestogenic (MGA) activities, and
deliver either single hormones [e.g., Finaplix-H
(Intervet, Millsboro, DE, USA), 200 mg TbA;
Ralgro (Mallinckrodt Veterinary, Mundlein,
IL, USA), 36 mg zeranol] or a mixture [e.g.,
Synovex-H (Fort Dodge Animal Health-
Wyeth, Madison, NJ, USA), 200 mg testos-
terone propionate plus 20 mg E2 benzoate]
(Lange et al. 2001). The progestogen agonist
MGA was devoid of estrogenic and androgenic
activity; however, Meyer (2001) reported that
administering MGA to female cattle increases
their plasma E2 levels.
We collected runoff water from feedlots
where animals were treated with anabolic
steroids. A signiﬁcant portion of these steroids
and their metabolites are excreted as conju-
gates (Schiffer et al. 2001), which are not
extracted by DCM. However, conjugates are
metabolized by bacteria into their DCM-
extractable free form in sewage and surface
waters (Irwin et al. 2001). Hence, the results
presented here may underestimate actual
exposure if conjugates were present in the
water. We did not know a priori what type of
hormone implant was used in this feedlot and
were not able to obtain this information upon
request. Therefore, we ﬁrst measured the total
estrogenic and androgenic activity at different
points downstream of one such operation to
assess the exposure of fish (Orlando et al.
2004). We then analyzed the water extracts to
assess the presence of pharmaceuticals fre-
quently used as anabolic steroids (this study).
Bioassays measure the total activity of
mixtures of chemicals that act through the
same receptor systems (Silva et al. 2002);
activity is expressed in concentration units of
the standard (Soto et al. 1997). These data are
then contrasted with instrumental analyses of
the sample. Ideally, the analytes measured
account for the total hormonal activity found
in the bioassay. The presence of additional
active compounds in the mixture is suggested
when the instrumental analysis reveals a lower
theoretical activity than the bioassay detects.
Androgenic activity. The total androgenic
activity measured by A-SCREEN seems to
have originated in the feedlots, because it was
highest at site 1 and decreased to < 40% at site
2, located 0.5 km downstream. The intermedi-
ate contamination site, which also drained
feedlots, had androgenic activity comparable
with that of site 2, which was 2-fold higher
than in the reference site. At the time of sample
collection, sites 4 and 5 were believed to be free
of feedlot exposure. The hormonal activity in
the reference sites could be a result of manure
water slurry that had been sprayed on crops in
the vicinity, which we learned of after the
water samples had been collected, processed,
and assayed.
Marginal levels of Tb and its metabolites
(representing 0.1–1.1% of the total androgenic
activity) were detected. Hence, the androgenic
activity may be attributed to natural andro-
gens. The octanol–water partition coefﬁcient
of natural androgens (3.3 for testosterone) sug-
gests a potential for sorption to organic matter
and, thus, a higher concentration in sediment
(not analyzed) than in water.
Estrogenic activity. Remarkably, estrogenic
activities at sites 1 and 2 would be sufﬁcient to
produce a significant effect on target cells.
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Table 1. E1 concentration (pg/L) in water collected in July 1999, measured by EIA and GC-HRMS.
EIA GC-HRMS
pg/La pMb E2Eq (pM)c E2Eq (%)d pg/Le pMb E2Eq (pM)c E2Eq (%)d
1 1,650 6.1 0.265 15.36 2,536 9.4 0.408 23.61
2<  530 354 1.3 0.057 2.55
3 370 1.4 0.060 9.10 1,066 3.9 0.172 26.21
4<  210 246 0.9 0.040 5.09
5 1,600 5.9 0.257 33.95 2,164 8.0 0.348 45.92
6 270 1.0 0.043 3.77 332 1.2 0.053 4.64
T1 < 5 60 0.22 0.010
T2 < 1 64 0.24
Blank < 1 56.42f
Spike NAg 166f,g
NA, not assayed.
apg/L E1 as determined by EIA. bpg/L converted to pM concentration. cpM E1 converted into E2Eq by multiplying by RPP.
dRatio of E2Eq of E1 divided by the total E2Eq measured by the E-SCREEN assay (Figure 3). epg/L E1 as determined by
GC-HRMS. fThe approximately 50–60 pg/L excess in the water blanks and the E1-spiked sample indicates contamination
during processing at the analytical facility; the blanks were negative for 17β-E2 and 17α-E2, and the corresponding spiked
samples were detected at 91 and 98 pg/mL. gSpiked with 100 pg/L of the test compound. 
Table 2. Total androgen and estrogen activity in water samples recollected during 2000 and 2001.
Sample AEq (pM) E2Eq (pM) E2Eq calculated from RPP
September 2000
Site 1 3.75 ± 11.5% 3.675 ± 0.9% 1.3 pM/La/1.2 pM/Lb
Site 6 Toxic/NDc Toxic/ND 0.1 pM/La/0.4pM/Lb
June 2001d
Site 1 1.03 ND
Site 3 0.54 ND
Site 6 0.19 ND
Blank 1 ND ND
Blank 2 ND ND
ND, not detectable. 
aCalculated from EIA (Table 3). bCalculated from GC-HRMS data (Table 3) and RPP of E1.
cSample was toxic at all dilutions
more concentrated than 1-fold greater than the original water sample. dAfter cleanup with immunoaffinity columns for
Tb/19-nortestosterone.
Table 3. Estrogen levels (pg/L) in water samples collected in September 2000 as detected by EIA and
GC-HRMS.
E1 17α-E2 17β-E2
Site EIA GC-MS EIA GC-MS EIA GC-MS
1 8,300 7,682 < 3,800 ND < 3,200 ND
6 900 2,434 35 26 84 ND
ND, not detectable.
Table 4. Androgen levels (pg/L) in water samples collected in July 2001 as determined by EIAa.
Sample Tb-17β Tb-17α TbO
Site 1 1.5 5.4 7.6
Site 3 1.3 35 16
Site 6 < 0.4 1.6 1.9
Blank 1 < 0.3 1.6 2.3
Blank 2 < 0.3 10 8.8
aAfter cleanup with immunoafﬁnity columns for Tb/19-nortestosterone.Resorcylic acid lactones were not detected;
instead, E1 was detected in all sites and repre-
sented up to 46% of the total estrogenic activ-
ity. 17α-E2 and 17β-E2 were barely detectable
in some samples. The main metabolite of
17β-E2 in cattle excreta is 17α-E2. We were
not surprised, however, to ﬁnd that the main
estrogen detected was E1. It has been estab-
lished that microorganisms in the environment
degrade estrogens and that E2 is rapidly trans-
formed to E1 in river water and in sediments
(Jürgens et al. 2002). The log octanol–water
partition coefﬁcients of E2 and E1 are reported
to be in the range of 3–4, indicating sorption
potential to organic matter. Therefore, higher
concentrations of estrogens may be present in
the sediment. This is especially important con-
cerning E1, which is persistent (Environment
Agency 2002). The fact that E1 did not
account for all the estrogenic activity suggests
that estrogenic compounds other than those
analyzed may have been present. DCM also
extracts pesticides, plasticizers, and other xeno-
estrogens. We detected diethylphthalate
(2 ng/L), atrazine (6 ng/L), metolachlor
(3.3 ng/L), and cyanazine (1.1 ng/L) in some
of the feedlot samples, but not in drinking
water. Diethylphthalate is estrogenic (Harris et
al. 1997), and although some commonly used
herbicides (i.e., atrazine) are not estrogenic,
they do appear to activate aromatase and thus
increase estrogen production in alligators
(Crain et al. 1997) and frogs (Hayes et al.
2002) and in some fish and mammalian cell
lines (Sanderson et al. 2001).
It is worth noting that water samples taken
in July 2002 and processed by affinity chro-
matography to purify Tb were devoid of estro-
genic activity. This shows that the androgens
present in these preparations do not produce
false positives when tested by the E-SCREEN
assay and it also confirms our prior results
(Soto et al. 1998; Soto et al. 1999). Drinking
water from wells showed neither estrogenic
nor androgenic activity.
In summary, these data indicate that signiﬁ-
cant estrogenic and androgenic activity is
released into water by feedlot operations. Our
findings are compatible with the hypothesis
that the animals in this feedlot may have been
treated with an anabolic mixture of androgen
and estrogen, such as testosterone propionate
and estradiol benzoate.
These data support the findings of
Orlando et al. (2004) regarding masculiniza-
tion of female ﬁsh captured at sites 2 and 3.
This effect could be a consequence of andro-
gen exposure (at least 2-fold higher at sites 2
and 3 than at site 6), and the demasculiniza-
tion found at these two sites may be due to
the combined effect of estrogens and andro-
gens, which may have altered the regulation
of gonadotropin-releasing factors and/or
gonadotropins in the exposed fish. The fact
that fish are affected suggests the need for
future studies to further examine the mecha-
nisms leading from exposure to the observed
effects. On one hand, difﬁculties regarding the
isolation of natural hormones and anabolic
steroids require new puriﬁcation protocols and
sensitive analytical techniques for assessing
exposure. On the other hand, our data high-
light the usefulness of the E-SCREEN and
A-SCREEN assays because they allow the esti-
mation of total estrogen and androgen exposure
of ﬁsh and other wildlife using a single-step,
easily performed extraction method.
These ﬁndings contribute to the increasing
literature documenting the contamination of
water bodies in the United States and Europe
with numerous bioactive agents, including
natural hormones, xenohormones, and phar-
macologic agents (Allen et al. 1999; Kolpin
et al. 2002; Vethaak et al. 2002), and point to
the urgent need to take steps to curtail envi-
ronmental degradation caused by the release of
these chemicals into bodies of water.
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